Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.

Nail loss after teriflunomide treatment: a new potential adverse event

MANCINELLI, LUCA;AMERIO, Paolo;DI IOIA, MARIA;DI TOMMASO, VALERIA;DE LUCA, Giovanna;ONOFRJ, Marco;
2017-01-01

Abstract

Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.
File in questo prodotto:
File Dimensione Formato  
Mancinelli_Multiple Sclerosis and Related Disorders_2017.pdf

Solo gestori archivio

Descrizione: Articolo principale
Tipologia: Documento in Post-print
Dimensione 279.47 kB
Formato Adobe PDF
279.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/676216
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact